We are an agile team that shares a passion for animals and solving complex problems.

  • Founder, CEO | LinkedIn

    Can is a molecular biologist turned entrepreneur, experienced in technology development. His prior work focused on genomics, cancer, and biopharmaceuticals in both academia and the industry.

    Can is passionate about science, healthcare, finance and unsurprisingly, cats. He has been an investor in public and private markets and demonstrated a keen eye for future value-drivers.

    Can grew up in Istanbul, Turkey — the cat capital of the world. Kedi means cat in Turkish, and Can named all of his after biologists. He lived in Europe for 14 years.

  • Co-Founder, COO | LinkedIn

    From researching drug metabolism and gut microbes to project management and support, Morgan’s strengths emerge in knowledge translation and scientific communication.

    She is a computational life scientist and systems thinker at heart, who enjoys art, culture, technology and storytelling.

    Morgan grew up in the American Midwest, surrounded by cats and dogs that her family rescued and spoiled. She has made Europe her home for the last decade.

Meet Kedi’s Reason:

Cosmo

We learned firsthand how the absence of advanced therapeutic options negatively impacts veterinary care.

Our 18 month old kitten was diagnosed with late stage lymphoma in October 2022, and we were outraged by the inadequate therapeutic landscape. Harsh chemotherapy drugs only gave us a few more precious months together.

Metamorphosing grief into purpose, we have since been devoted to bringing the very best solutions that biotechnology can offer to veterinary pharmaceutical R&D.

We strive to prevent undue loss of life in other interspecies families.

Together with our Chief Morale Officer, Stella*, it’s our way of honoring Cosmo’s memory.

*Cosmo’s biological mom